Fundz

Aprea Therapeutics Appoints Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer

PUBLIC · APREMay 02, 2024

Company

Aprea Therapeutics

DoylestownBiotechnologyHealth CareScience And EngineeringTherapeutics

Description

Aprea Therapeutics, Inc. has appointed Nadeem Q. Mirza as the Chief Medical Officer, effective May 1, 2024

Quick answer

Aprea Therapeutics Appoints Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer (May 2, 2024). Aprea Therapeutics is based in Doylestown, Pennsylvania, United States.

What did Aprea Therapeutics announce on May 2, 2024?
Aprea Therapeutics, Inc. has appointed Nadeem Q. Mirza as the Chief Medical Officer, effective May 1, 2024
What does Aprea Therapeutics do?
Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality.
Where is Aprea Therapeutics based?
Aprea Therapeutics is based in Doylestown, Pennsylvania, United States.
Which similar companies made leadership changes around the same time?
Nomad Power Solutions, Inc. (June 5, 2024), Shape Therapeutics (May 2, 2024), PDS Biotech (May 2, 2024) and Immunome Inc. (May 2, 2024) also announced leadership changes within 45 days of Aprea Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Aprea Therapeutics, and when

A new leader at Aprea Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Aprea Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aprea Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aprea Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aprea Therapeutics

Location

Doylestown, Pennsylvania, United States

About

Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. We exist to ensure that cancer doesn't interrupt life's possibilities and dreams. We do this through our unique approach to synthetic lethality that is revolutionizing the future of cancer treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aprea Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nadeem
Senior decision-maker at this company
••••••••@••••••••

See Nadeem's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aprea Therapeutics's next move

Learn about Strategic plan

Aprea Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.